Combination therapy for treating cancer and diagnostic assays for use therein

Details for Australian Patent Application No. 2010326090 (hide)

Owner Abbott Laboratories

Inventors Shah, Omar Jameel; Shen, Yu; Lin, Xiaoya; Anderson, Mark; Huang, Xiaoli; Li, Junling; Li, Leiming

Agent Spruson & Ferguson

Pub. Number AU-A-2010326090

PCT Pub. Number WO2011/068863

Priority 12/630,957 04.12.09 US

Filing date 1 December 2010

Wipo publication date 9 June 2011

International Classifications

A61K 31/454 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61K 31/635 (2006.01)

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/48 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

Event Publications

31 May 2012 PCT application entered the National Phase

  PCT publication WO2011/068863 Priority application(s): WO2011/068863

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010326095-Triangular shipping container with polygonal inner support

2010326076-System for transmitting electrical current to a bodily tissue